Evolving Brand-Name And Generic Drug Competition May Warrant A Revision Of The Hatch-Waxman Act-Reference-Cited by-同舟云学术

Evolving Brand-Name And Generic Drug Competition May Warrant A Revision Of The Hatch-Waxman Act

Published:2011-11 Issue:11 Volume:30 Page:2157-2166
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Grabowski Henry G.¹,Kyle Margaret²,Mortimer Richard³,Long Genia⁴,Kirson Noam⁵

Affiliation:

1. Henry G. Grabowski ( ) is a professor emeritus of economics and director of the Program in Pharmaceutical and Health Economics at Duke University, in Durham, North Carolina.

2. Margaret Kyle is a professor of management at the Toulouse School of Economics, in France.

3. Richard Mortimer is a vice president at Analysis Group, in Boston, Massachusetts.

4. Genia Long is managing principal at Analysis Group.

5. Noam Kirson is a manager at Analysis Group.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference18 articles.

1. Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century after the 1984 Waxman-Hatch Legislation

2. Are the Economics of Pharmaceutical Research and Development Changing?

3. Competition between Generic and Branded Drugs

4. Generic Entry and the Pricing of Pharmaceuticals

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Settled: Patent characteristics and litigation outcomes in the pharmaceutical industry;International Review of Law and Economics;2023-12

2. Does the United States Need Better Policies Governing Generic Drug Use?;Value in Health;2023-03

3. Analysis of Patent and Regulatory Exclusivity for Novel Agents in China and the United States: A Cohort Study of Drugs Approved Between 2018 and 2021;Clinical Pharmacology & Therapeutics;2022-05-22

4. Market Exclusivity of the Originator Drugs in South Korea: A Retrospective Cohort Study;Frontiers in Public Health;2021-04-06

5. Continuing trends in U.S. brand-name and generic drug competition;Journal of Medical Economics;2021-01-01